🦠 Lactobacillus Bifidobacterium Colonization Simulator

Baseline Gut Flora

A healthy gut hosts trillions of resident bacteria in stable balance.

• ~1,000: Resident gut species (in a healthy adult)
• ~38 T: Total microbial cells (roughly equal to human cells)
• 2: Dominant phyla (Firmicutes and Bacteroidetes)
• High: Baseline stability (niches already fully occupied)

A crowded, occupied ecosystem

Resident bacteria fill nearly every available gut niche already.

Colonization resistance

Established flora actively resists new microbial arrivals by default.

Why baseline matters

Any probiotic must compete against this dense standing population.

Probiotic Ingestion

A capsule delivers live Lactobacillus and Bifidobacterium strains into the gut.

• 1–10 B: Typical dose (CFU per capsule)
• Variable: Stomach acid survival (strain-dependent tolerance)
• ~24–72 h: Transit time (mouth to colon)
• 2: Common genera (Lactobacillus, Bifidobacterium)

Surviving the gauntlet

Organisms must survive stomach acid and bile before reaching the colon.

Strain-specific formulations

Encapsulation and strain choice affect how many organisms arrive alive.

Arrival, not settlement

Reaching the gut does not guarantee lasting colonization there.

Transient Colonization

During continuous dosing, probiotic organisms remain detectable in stool and mucosa.

• Daily dosing: Detection window (levels rise while supplementing)
• <1–5%: Peak share of flora (of total gut bacteria)
• Weak: Mucosal adherence (mostly transient, non-adherent)
• qPCR / culture: Detection method (strain-specific tracking)

Present but not settled

Detectable levels reflect steady dosing, not permanent engraftment.

A dose-dependent plateau

Organism counts rise with days of use, then level off.

Passing through

Most probiotic strains pass through rather than take root.

Competition With Resident Flora

Established microbiome members outcompete probiotics for nutrients and attachment sites.

• Low: Niche availability (most sites already occupied)
• High: Nutrient competition (shared fermentable substrates)
• Rare: Engraftment success (few strains persist long-term)
• Numbers: Resident advantage (vast pre-existing population)

Outnumbered from the start

Resident bacteria vastly outnumber any incoming probiotic dose.

Competitive exclusion

Established species exclude newcomers from limited attachment niches.

A losing numbers game

Sustained dosing is needed just to hold a small share.

Post-Discontinuation Decline

Once supplementation stops, probiotic levels fall back toward baseline within weeks.

• Days: Clearance onset (decline begins almost immediately)
• ~2–4 wks: Return to baseline (typical clearance window)
• Uncommon: Long-term engraftment (for most commercial strains)
• Full: Resident recovery (dominance restored after clearance)

Confirming transience

Rapid decline confirms most probiotics never truly colonized.

Resident flora reclaims ground

Established bacteria quickly refill niches the probiotic briefly held.

Implications for use

Lasting benefit likely requires continuous, repeated supplementation.